masthead-news

News & Events

Nature Research Custom Media webcast: A comparison of gene expression technologies in clinical applications

Dr. Kerry Culm-Merdek of Oncologie and Dr. Marian Navratil of HTG Molecular Diagnostics will describe their cross-platform comparison study between RNA-Seq and HTG’s translational research profiling panel, the HTG EdgeSeq Precision Immuno-Oncology Panel (PIP) for measuring gene expression.

Read More

 

HTG Molecular Diagnostics Reports Second Quarter 2020 Results

Call scheduled for today, August 11, at 4:30pm ET TUCSON, Ariz. , Aug. 11, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the quarter ended June 30, 2020

Read More

Posted on:
 

HTG Introduces HTG EdgeSeq Reveal RUO Oncology Applications

TUCSON, Ariz. , Aug. 04, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Reveal RUO oncology applications, which are expected to

Read More

Posted on:
 

HTG Launches New HTG EdgeSeq Pan B-Cell Lymphoma Panel

TUCSON, Ariz. , July 28, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the launch and immediate availability of the HTG EdgeSeq Pan B-Cell Lymphoma Panel in the United States and

Read More

Posted on:
 

HTG Announces Recipients of Its 2020 HTG EdgeSeq Autoimmune Panel Research Grants

TUCSON, Ariz., July 23, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced Vinodh Pillai, M.D., Ph.D., Assistant Professor of Pathology and Laboratory Medicine at the Children’s Hospital of Philadelphia, and Thomas Dörner, MD, Professor of Rheumatology and Hemostaseology at Charité University Hospitals, Berlin, as award recipients of its 2020 HTG EdgeSeq Autoimmune Panel Research Grants.

Read More

Posted on:
 

Page last updated September 03, 2020